Effect of Reducing Sedentary Behavior on Blood Pressure
Effect of Reducing Sedentary Behavior on Blood Pressure
批准号:
10198014
负责人:
MATTHEW F MULDOON
金额:
$61.05万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-15 至 2024-06-30
关键词:
AccountingAcuteAddressAdherenceAdultAffectAldosteroneAmericanAttentionBehaviorBehavior TherapyBehavioralBlood PressureBlood VesselsCardiovascular DiseasesCessation of lifeClinicalComputersCounselingCoupledCross-Over StudiesDataDiastolic blood pressureDistalDoseEnergy MetabolismEvaluationExerciseFutureGoalsGuidelinesHealthHealth BenefitHealth Care CostsHourHypertensionIndividualInterruptionInterventionIntervention StudiesLaboratoriesLaboratory StudyLeadLeisuresLightLinkMeasuresMediatingModificationMonitorMorbidity - disease rateMovementObesityObservational StudyOccupationalOccupationsOutcomePerceptionPersonsPharmacotherapyPhysical activityPhysiologic pulsePlasmaPopulationPosturePublic HealthRandomized Clinical TrialsRecommendationReninRenin-Angiotensin-Aldosterone SystemResearchResearch DesignRestRiskRisk FactorsStreamStructureTelephoneTestingText MessagingTimeWalkingWristadverse outcomearmarterial stiffnessbaseblood pressure reductionblood pressure regulationcardiometabolic riskcardiorespiratory fitnesscardiovascular disorder riskcardiovascular healthcardiovascular risk factorefficacy evaluationfight againstfitnessimprovedinnovationinsulin sensitivityintervention effectlight intensitymoderate-to-vigorous physical activitymortalitynovelnovel strategiesnovel therapeutic interventionprehypertensionprimary outcomeprognosticprogramsrandomized trialrecruitresponsesecondary outcomesedentary lifestyletherapy designtooltrial comparingvigorous intensity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
Elevated blood pressure (BP), including hypertension (HTN) and preHTN, affects 2 in 3 American adults and is
a major contributor to cardiovascular disease (CVD) morbidity, mortality, and healthcare costs. Despite
widespread use of pharmacotherapy, only about half of HTN is controlled, highlighting a need for innovative
strategies to decrease the burden of elevated BP. Though regular exercise in the form of moderate-to-vigorous
physical activity (MVPA) occurring in bouts of at least 10 minutes is recommended to decrease BP, we propose
that reducing time spent sitting or `sedentary behavior' (SED) is a distinct, novel strategy that could lower BP in
individuals with preHTN and HTN. Recent occupational and leisure changes (e.g., computers, video streaming)
have resulted in more than half of the American day being spent in SED. At the same time, many observational
studies have linked excessive SED with adverse outcomes, including HTN and CVD. Moreover, same day
laboratory studies suggest that reducing or interrupting SED decreases BP acutely and our preliminary data
suggest that systolic BP (SBP) is reduced by 4-6 mmHg after a 12-week SED intervention. Yet, there have been
no robust, randomized trials of sufficient size and duration to demonstrate that reducing SED has sustained
benefits on BP. Before clinical or public health SED recommendations can be made, such experimental evidence
is imperative. Thus, the goal of this application is to demonstrate the efficacy of SED reduction to decrease BP
in a 3-month randomized, clinical trial (intervention vs. control) in 300 adults (150 per group) with pre-to-Stage I
HTN who have structured, prolonged SED as desk workers. We will use our proven approach that intervenes on
multiple levels (individual, environmental modification with a sit-stand desk attachment) and utilizes behavioral
strategies (individual counseling, self-monitoring, external prompting with a wrist-worn monitor light-intensity
physical activity (LPA) (standing, light movement) and short spurts (<10 min) of activity (sporadic MVPA) as
replacement behaviors. We will comprehensively study the effects of our intervention on vascular health by
assessing resting BP, ambulatory BP, and carotid-femoral pulse wave velocity (cfPWV) (Aim 1) and key potential
mechanisms (plasma renin activity, aldosterone) (Aim 2). We will use objective activity monitoring to evaluate
dose-response relationships between amount of achieved SED reduction (and resulting increases in LPA and
sporadic MVPA) with changes in outcomes (Aim 3). We will also study adiposity, fitness, and insulin sensitivity
as exploratory outcomes that could change with our intervention, and if so, might relate to BP. Results from this
study will determine whether decreasing SED can improve BP and vascular health and inform the necessary
dose of SED reduction for clinically meaningful benefits. Also, evaluation of our novel intervention approach will
inform future interventions for SED research and for designing translatable, population-level programs. If SED
reduction improves BP, it could provide an important additional tool in the fight against elevated BP and CVD.
and text messaging). These strategies will facilitate a targeted 2-4 hr/day SED reduction by increasing
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1093/occmed/kqab011
发表时间:
2021-04-09
期刊:
Occupational medicine (Oxford, England)
影响因子:
--
作者:
[Barone Gibbs B, Kline CE, Huber KA, Paley JL, Perera S]
通讯作者:
Perera S
Multilevel mobile health program to improve rural hypertension
-
批准号:10338415
-
项目类别:
-
资助金额:$72.58万
-
财政年份:2022
-
负责人:MATTHEW F MULDOON
-
依托单位:
Multilevel mobile health program to improve rural hypertension
-
批准号:10644984
-
项目类别:
-
资助金额:$71.6万
-
财政年份:2022
-
负责人:MATTHEW F MULDOON
-
依托单位:
Omega-3 Fatty Acids, Cardiovascular Risk and Behavior
-
批准号:8216010
-
项目类别:
-
资助金额:$33.61万
-
财政年份:2011
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF OMEGA-3 FATTY ACIDS ON COGNITIVE PERFORMANCE
-
批准号:8090503
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2009
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF OMEGA-3 FATTY ACIDS ON COGNITIVE PERFORMANCE
-
批准号:7878003
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2009
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF OMEGA-3 FATTY ACIDS ON COGNITIVE PERFORMANCE
-
批准号:8293389
-
项目类别:
-
资助金额:$7.42万
-
财政年份:2009
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF OMEGA-3 FATTY ACIDS ON COGNITIVE PERFORMANCE
-
批准号:7648335
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2009
-
负责人:MATTHEW F MULDOON
-
依托单位:
Omega-3 Fatty Acids, Cardiovascular Risk and Behavior
-
批准号:7318147
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2007
-
负责人:MATTHEW F MULDOON
-
依托单位:
Distress, Fish Oil, Inflammation, and Heart Disease
-
批准号:6958824
-
项目类别:
-
资助金额:$11.14万
-
财政年份:2005
-
负责人:MATTHEW F MULDOON
-
依托单位:
Distress, Fish Oil, Inflammation, and Heart Disease
-
批准号:7140283
-
项目类别:
-
资助金额:$10.88万
-
财政年份:2005
-
负责人:MATTHEW F MULDOON
-
依托单位:
Blood pressure, reactivity, metabolism and serotonin
-
批准号:6564892
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2002
-
负责人:MATTHEW F MULDOON
-
依托单位:
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
-
批准号:2910545
-
项目类别:
-
资助金额:$42.74万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
-
批准号:2467659
-
项目类别:
-
资助金额:$39.97万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
-
批准号:6183192
-
项目类别:
-
资助金额:$43.46万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF CHOLESTEROL REDUCTION ON BEHAVIOR
-
批准号:3365432
-
项目类别:
-
资助金额:$32.71万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
-
批准号:6389167
-
项目类别:
-
资助金额:$34.2万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
EFFECTS OF CHOLESTEROL REDUCTION ON BEHAVIOR
-
批准号:3365433
-
项目类别:
-
资助金额:$39.34万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
-
批准号:2222818
-
项目类别:
-
资助金额:$56.07万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
CHOLESTEROL REDUCTION EFFECTS ON BEHAVIOR
-
批准号:2222819
-
项目类别:
-
资助金额:$42.67万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
SUPPLEMENT EFFECTS OF CHOLESTEROL REDUCTION ON BEHAVIOR
-
批准号:2222817
-
项目类别:
-
资助金额:$14.15万
-
财政年份:1992
-
负责人:MATTHEW F MULDOON
-
依托单位:
海外基金